Benzyl 4-(chlorosulfonyl)piperidine-1-carboxylate

Catalog No. :
ACIAJV065
CAS No. :
287953-54-2
Molecular Formula :
C13H16ClNO4S
Molecular Weight :
317.79

IUPAC Name:benzyl 4-(chlorosulfonyl)piperidine-1-carboxylate

Benzyl 4-(chlorosulfonyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$97.00Login to see priceIn stockInquiry
5g95%$339.00Login to see priceIn stockInquiry
10g95%$576.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 4-(chlorosulfonyl)piperidine-1-carboxylate
IUPAC Namebenzyl 4-(chlorosulfonyl)piperidine-1-carboxylate
MDL No.MFCD05664659
Molecular FormulaC13H16ClNO4S
Molecular Weight317.79
SMILESO=C(N1CCC(S(=O)(Cl)=O)CC1)OCC2=CC=CC=C2
InChI KeyHEGCWAOVTPVFBJ-UHFFFAOYSA-N
Synonym287953-54-2 | benzyl 4-(chlorosulfonyl)piperidine-1-carboxylate | N-Benzyloxycarbonyl-4-piperidinesulfonyl chloride | benzyl 4-chlorosulfonylpiperidine-1-carboxylate | N-CBZ-4-piperidine sulfonyl chloride | N-benzyloxycarbonyl-4-piperidine sulfonyl chloride | 1-PIPER
CAS No.287953-54-2
PubChem CID21931260

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACIAJV065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHMNQ624 route compound structure diagram
    ACHMNQ624146827-60-3 In Stock
  2. Then
  3. ACIAJV065 route product structure diagram
    ACIAJV065287953-54-2 In Stock
Inquiry

2. ACIAJV065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIAJV065 route product structure diagram
    ACIAJV065287953-54-2 In Stock
Inquiry

Comments (0)